Elaine Fajardo, MD
Assistant Professor of Medicine (Pulmonary, Critical Care and Sleep Medicine); Medical Director for Respiratory Therapy, Internal Medicine
Research & Publications
Biography
News
Coauthors
Selected Publications
- Pressure-Regulated Ventilator Splitting for Disaster Relief: Design, Testing, and Clinical ExperienceRaredon MSB, Fisher C, Heerdt PM, Schonberger RB, Nargi A, Nivison S, Fajardo E, Deshpande R, Akhtar S, Greaney AM, Belter J, Raredon T, Zinter J, McKee A, Michalski M, Baevova P, Niklason LE. Pressure-Regulated Ventilator Splitting for Disaster Relief: Design, Testing, and Clinical Experience. Anesthesia & Analgesia 2021, 134: 1094-1105. PMID: 34928890, DOI: 10.1213/ane.0000000000005825.
- 284: METHYLPREDNISOLONE VERSUS USUAL CARE FOR COVID-19-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROMEOwusu K, Ammar M, Ammar A, Chess A, Siner J, Fajardo E, Chichra A. 284: METHYLPREDNISOLONE VERSUS USUAL CARE FOR COVID-19-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME. Critical Care Medicine 2021, 50: 127-127. DOI: 10.1097/01.ccm.0000807460.83646.b2.
- Ventilator Sharing Using Volume-controlled Ventilation during the COVID-19 PandemicMilner A, Siner JM, Balcezak T, Fajardo E. Ventilator Sharing Using Volume-controlled Ventilation during the COVID-19 Pandemic. American Journal Of Respiratory And Critical Care Medicine 2020, 202: 1317-1319. PMID: 32744456, PMCID: PMC7605199, DOI: 10.1164/rccm.202006-2452le.
- CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH COVID-19 WITH RESPIRATORY FAILURE REQUIRING EXTRACORPOREAL MEMBRANE OXYGENATIONFouad J, Singh I, Khosla A, Szabo C, Tantawy H, Razo-Vazquez A, Geirsson A, Bonde P, Fajardo E, Joseph P, Siner J, Chichra A. CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH COVID-19 WITH RESPIRATORY FAILURE REQUIRING EXTRACORPOREAL MEMBRANE OXYGENATION. CHEST Journal 2020, 158: a703-a704. PMCID: PMC7548617, DOI: 10.1016/j.chest.2020.08.660.
- History and Physical Examination1. Fajardo, E. and L. Davis. History and Physical Examination. In Murray & Nadel’s Textbook of Respiratory Medicine, 7th Edition, eds V. Courtney Broaddus, Joel D. Ernst, Talmadge E. King, Jr., Stephen C. Lazarus, Kathleen F. Sarmiento, Lynn M. Schnapp, Renee D. Stapleton, Elsevier, Amsterdam, Netherlands, 2019.
- Management of Hyperosmolar Hyperglycemic Syndrome1. Fajardo, E. Management of Hyperosmolar Hyperglycemic Syndrome. In Evidence-Based Critical Care: A Case Study Approach, 2nd edition. Eds Robert C. Hyzy, Springer International Publishing, Switzerland, 2019.
- Management of Hyperosmolar Hyperglycemic Syndrome2. Fajardo, E. Management of Hyperosmolar Hyperglycemic Syndrome. In Evidence-Based Critical Care: A Case Study Approach, 1st edition. Eds Robert C. Hyzy, Springer International Publishing, Switzerland, 2017, pp.441-446.
- Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum.Nolan A, Fajardo E, Huie ML, Condos R, Pooran A, Dawson R, Dheda K, Bateman E, Rom WN, Weiden MD. Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum. PloS One 2013, 8: e59461. PMID: 23527200, PMCID: PMC3603887, DOI: 10.1371/journal.pone.0059461.